Summary
- Main use
- Improvement of chronic hepatitis accompanied by persistent elevation of ALT
- Who takes it
- Adults
- Adult dose
- Adults: Administer 7.5 mg biphenyl dimethyl dicarboxylate orally per dose, 3 times daily. If symptoms do not improve after 1 ~ 2 months of use, the dose may be increased to 15 mg per dose, 3 times daily. When ALT levels return to normal, administer 7.5 mg per dose orally, 2 times daily. The usual treatment period is 6 ~ 12 months. The dose may be adjusted as appropriate according to symptoms.
Ingredients
- Manufacturer
- Korea Chorus Co., Ltd.
Efficacy & effects
Improvement of chronic hepatitis accompanied by persistent elevation of ALT
- Chronic hepatitis with continuously elevated ALT levels.
View approved original textHide original text
Chronic hepatitis is a condition characterized by long-term inflammation of the liver, and it is accompanied by continuously elevated ALT levels. This condition may lead to decreased liver function and damage to liver tissue, thus requiring appropriate treatment. The medication is used to improve liver function and reduce inflammation in patients with chronic hepatitis.
How to take
Adult dose
Adults: Administer 7.5 mg biphenyl dimethyl dicarboxylate orally per dose, 3 times daily. If symptoms do not improve after 1 ~ 2 months of use, the dose may be increased to 15 mg per dose, 3 times daily. When ALT levels return to normal, administer 7.5 mg per dose orally, 2 times daily. The usual treatment period is 6 ~ 12 months. The dose may be adjusted as appropriate according to symptoms.
Precautions
This medication should not be used by patients who are allergic to this medication or its components. Extra caution should be exercised when using this medication in patients with chronic active hepatitis or cirrhosis. Side effects such as dry mouth, nausea, and skin rash may occur when taking this medication; these symptoms may subside when taken together with allergy medication. Temporary yellowing of the skin may occur, but this will resolve by discontinuing the medication or taking jaundice treatment medication. Nausea or abdominal bloating may rarely occur but usually goes away quickly. The use of this medication in conjunction with Inosine may result in improved ALT levels, a liver function indicator. Women who are pregnant, may become pregnant, or are breastfeeding should not use this medication. Elderly patients may have reduced physical functions, so caution should be taken to adjust the dosage accordingly. While the liver function test results are generally stable during the use of this medication, liver enzyme levels may increase upon discontinuation, and improvement will occur upon resuming the medication. This medication should be stored in a safe place out of reach of children, and it is crucial to keep it in the original container, as transferring it to another container may degrade the quality or lead to improper dosing.
Side effects
- Dry mouth
- nausea
- skin rash
- transient jaundice
- vomiting
- abdominal bloating
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to prevent air or moisture from entering. This helps to maintain the effectiveness of the medication for a longer period and prevents deterioration.
Appearance and packaging
Appearance
An upper orange capsule and a lower white hard capsule containing a milky white spherical content.
Package unit
30 capsules/bottle, 90 capsules/bottle, 500 capsules/bottle, 10 capsules/PTP*10
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
